Burning Rock Biotech Limited

NasdaqGM:BNR Stock Report

Market Cap: US$67.5m

Burning Rock Biotech Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Yusheng Han

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership16.9%
Management average tenure8.8yrs
Board average tenure4.5yrs

Recent management updates

Recent updates

Little Excitement Around Burning Rock Biotech Limited's (NASDAQ:BNR) Revenues

Jun 21
Little Excitement Around Burning Rock Biotech Limited's (NASDAQ:BNR) Revenues

Will Burning Rock Biotech (NASDAQ:BNR) Spend Its Cash Wisely?

Mar 25
Will Burning Rock Biotech (NASDAQ:BNR) Spend Its Cash Wisely?

There's No Escaping Burning Rock Biotech Limited's (NASDAQ:BNR) Muted Revenues

Feb 01
There's No Escaping Burning Rock Biotech Limited's (NASDAQ:BNR) Muted Revenues

Burning Rock Biotech Limited (NASDAQ:BNR) Shares Could Be 24% Below Their Intrinsic Value Estimate

Jul 12
Burning Rock Biotech Limited (NASDAQ:BNR) Shares Could Be 24% Below Their Intrinsic Value Estimate

Is Burning Rock Biotech (NASDAQ:BNR) In A Good Position To Deliver On Growth Plans?

Apr 28
Is Burning Rock Biotech (NASDAQ:BNR) In A Good Position To Deliver On Growth Plans?

We Think Burning Rock Biotech (NASDAQ:BNR) Needs To Drive Business Growth Carefully

Dec 23
We Think Burning Rock Biotech (NASDAQ:BNR) Needs To Drive Business Growth Carefully

Is Burning Rock Biotech (NASDAQ:BNR) In A Good Position To Invest In Growth?

Sep 20
Is Burning Rock Biotech (NASDAQ:BNR) In A Good Position To Invest In Growth?

Burning Rock Biotech GAAP EPS of -$0.37 misses by $0.01, revenue of $19.5M misses by $2.94M

Aug 31

Burning Rock Localizes As Investors Grow Impatient

Jun 06

We're Hopeful That Burning Rock Biotech (NASDAQ:BNR) Will Use Its Cash Wisely

Mar 24
We're Hopeful That Burning Rock Biotech (NASDAQ:BNR) Will Use Its Cash Wisely

Following Rough Year, Is Burning Rock Set To Turn The Corner?

Nov 17

Is Burning Rock Biotech (NASDAQ:BNR) Using Debt In A Risky Way?

Aug 27
Is Burning Rock Biotech (NASDAQ:BNR) Using Debt In A Risky Way?

A Look At The Intrinsic Value Of Burning Rock Biotech Limited (NASDAQ:BNR)

Jul 23
A Look At The Intrinsic Value Of Burning Rock Biotech Limited (NASDAQ:BNR)

Is Burning Rock Biotech (NASDAQ:BNR) Using Debt Sensibly?

May 13
Is Burning Rock Biotech (NASDAQ:BNR) Using Debt Sensibly?

Burning Rock Biotech Expands Test Portfolio In Bid For Growth

Dec 30

Burning Rock inks license pact with Oncocyte Corporation

Dec 15

Burning Rock Biotech prices upsized offering of 2.243M ADSs at $25.75/ADS

Dec 04

Burning Rock Biotech EPS misses by $0.08, beats on revenue

Nov 20

CEO

Yusheng Han (45 yo)

no data

Tenure

Mr. Yusheng Han is the Founder, Chairman and chief executive officer of Burning Rock Biotech Limited. Mr. Han has 16 year of experience in life science. From June 2011 to November 2013, he was an associate...


Leadership Team

NamePositionTenureCompensationOwnership
Yusheng Han
Founderno datano data16.92%
$ 11.4m
Xiaozhi Hu
Senior Director of Financeless than a yearno datano data
Zhihong Zhang
CTO & Director8.8yrsno datano data
Hao Liu
Senior Advisor9.3yrsno datano data

8.8yrs

Average Tenure

48yo

Average Age

Experienced Management: BNR's management team is seasoned and experienced (8.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Yusheng Han
Founderno datano data16.92%
$ 11.4m
Zhihong Zhang
CTO & Director1.5yrsno datano data
Feng Deng
Director8.3yrsno datano data
Gang Lu
Director10.5yrsno datano data
Wendy Hayes
Independent Director4.5yrsno datano data
Licen Lisa Xu
Independent Director2.5yrsno datano data

4.5yrs

Average Tenure

53yo

Average Age

Experienced Board: BNR's board of directors are considered experienced (4.5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 10:21
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Burning Rock Biotech Limited is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bo LiBofA Global Research
null nullChina International Capital Corporation Limited
Ziyu HeChina International Capital Corporation Limited